These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 37750244)

  • 1. Stellate Ganglion Block for the Treatment of COVID-19-Induced Olfactory Dysfunction: A Prospective Pilot Study.
    Peterson AM; Miller BJ; Kallogjeri D; Piccirillo JF; Kukuljan S; Roland LT; Schneider JS; Crock LW; Farrell NF
    Otolaryngol Head Neck Surg; 2024 Jan; 170(1):272-276. PubMed ID: 37750244
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of Combined Visual-Olfactory Training With Patient-Preferred Scents as Treatment for Patients With COVID-19 Resultant Olfactory Loss: A Randomized Clinical Trial.
    Khan AM; Piccirillo J; Kallogjeri D; Piccirillo JF
    JAMA Otolaryngol Head Neck Surg; 2023 Feb; 149(2):141-149. PubMed ID: 36580304
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and Safety of Saline Nasal Irrigation Plus Theophylline for Treatment of COVID-19-Related Olfactory Dysfunction: The SCENT2 Phase 2 Randomized Clinical Trial.
    Gupta S; Lee JJ; Perrin A; Khan A; Smith HJ; Farrell N; Kallogjeri D; Piccirillo JF
    JAMA Otolaryngol Head Neck Surg; 2022 Sep; 148(9):830-837. PubMed ID: 35797024
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of Gabapentin For Post-COVID-19 Olfactory Dysfunction: The GRACE Randomized Clinical Trial.
    Mahadev A; Hentati F; Miller B; Bao J; Perrin A; Kallogjeri D; Piccirillo JF
    JAMA Otolaryngol Head Neck Surg; 2023 Dec; 149(12):1111-1119. PubMed ID: 37733356
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exploring Olfactory Dysfunction as a Marker of Frailty and Postoperative Outcomes in Head and Neck Cancer.
    Mady LJ; De Ravin E; Vohra V; Lu J; Newman JG; Hall DE; Dalton PH; Rowan NR
    JAMA Otolaryngol Head Neck Surg; 2023 Sep; 149(9):828-836. PubMed ID: 37498617
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stellate ganglion block for treating post-COVID-19 parosmia.
    Naimi BR; Garvey E; Chandna M; Duffy A; Hunter SR; Mandloi S; Kahn C; Farquhar D; D'Souza G; Rabinowitz M; Rosen M; Toskala E; Roedl JB; Zoga A; Nyquist G; Rosen D
    Int Forum Allergy Rhinol; 2024 Jun; 14(6):1088-1096. PubMed ID: 38226898
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Olfactory dysfunction and training in children with COVID-19 infection: A prospective study Post-COVID pediatric olfactory training.
    Chan KH; Thomas BJ; Gilbert DD; Tong S; Teynor NJ; Friedman NR; Herrmann BW; Gitomer SA
    Int J Pediatr Otorhinolaryngol; 2024 Jan; 176():111799. PubMed ID: 38081110
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intensive Olfactory Training in Post-COVID-19 Patients: A Multicenter Randomized Clinical Trial.
    Pires ÍAT; Steffens ST; Mocelin AG; Shibukawa DE; Leahy L; Saito FL; Amadeu NT; Lopes NMD; Garcia ECD; Albanese ML; De Mari LF; Ferreira IM; Veiga CA; Jebahi Y; Coifman H; Fornazieri MA; Hamerschmidt R
    Am J Rhinol Allergy; 2022 Nov; 36(6):780-787. PubMed ID: 35866202
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development and Psychometric Validation of the Olfactory Dysfunction Outcomes Rating.
    Lee JJ; Mahadev A; Kallogjeri D; Peterson AM; Gupta S; Khan AM; Jiramongkolchai P; Schneider JS; Piccirillo JF
    JAMA Otolaryngol Head Neck Surg; 2022 Dec; 148(12):1132-1139. PubMed ID: 36264557
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Natural trajectory of recovery of COVID-19 associated olfactory loss.
    Khan AM; Lee J; Rammaha T; Gupta S; Smith H; Kannampallil T; Farrell N; Kallogjeri D; Piccirillo JF
    Am J Otolaryngol; 2022; 43(5):103572. PubMed ID: 35969913
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-lasting olfactory dysfunction in COVID-19 patients.
    Prem B; Liu DT; Besser G; Sharma G; Dultinger LE; Hofer SV; Matiasczyk MM; Renner B; Mueller CA
    Eur Arch Otorhinolaryngol; 2022 Jul; 279(7):3485-3492. PubMed ID: 34757458
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of platelet-rich plasma for COVID-19-related olfactory loss: a randomized controlled trial.
    Yan CH; Jang SS; Lin HC; Ma Y; Khanwalkar AR; Thai A; Patel ZM
    Int Forum Allergy Rhinol; 2023 Jun; 13(6):989-997. PubMed ID: 36507615
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development and Validation of a Novel At-home Smell Assessment.
    Gupta S; Kallogjeri D; Farrell NF; Lee JJ; Smith HJ; Khan AM; Piccirillo JF
    JAMA Otolaryngol Head Neck Surg; 2022 Mar; 148(3):252-258. PubMed ID: 35024772
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of classical olfactory training in patients with COVID-19-related persistent loss of smell.
    Yaylacı A; Azak E; Önal A; Aktürk DR; Karadenizli A
    Eur Arch Otorhinolaryngol; 2023 Feb; 280(2):757-763. PubMed ID: 35904631
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interventions for the treatment of persistent post-COVID-19 olfactory dysfunction.
    O'Byrne L; Webster KE; MacKeith S; Philpott C; Hopkins C; Burton MJ
    Cochrane Database Syst Rev; 2021 Jul; 7(7):CD013876. PubMed ID: 34291813
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Olfactory-related Quality of Life Adjustments in Smell Loss during the Coronavirus-19 Pandemic.
    Liu DT; Prem B; Besser G; Renner B; Mueller CA
    Am J Rhinol Allergy; 2022 Mar; 36(2):253-260. PubMed ID: 34704454
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Smell Changes and Efficacy of Nasal Theophylline (SCENT) irrigation: A randomized controlled trial for treatment of post-viral olfactory dysfunction.
    Lee JJ; Peterson AM; Kallogjeri D; Jiramongkolchai P; Kukuljan S; Schneider JS; Klatt-Cromwell CN; Drescher AJ; Brunworth JD; Piccirillo JF
    Am J Otolaryngol; 2022; 43(2):103299. PubMed ID: 34894449
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phantosmia May Predict Long-Term Measurable Olfactory Dysfunction After COVID-19.
    Leung JS; Cordano VP; Fuentes-López E; Lagos AE; García-Huidobro FG; Aliaga R; Díaz LA; García-Salum T; Salinas E; Toro A; Callejas CA; Riquelme A; Palmer JN; Medina RA; González G C
    Laryngoscope; 2022 Dec; 132(12):2445-2452. PubMed ID: 36149773
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Corticosteroid nasal irrigation as early treatment of olfactory dysfunction in COVID-19: A prospective randomised controlled trial.
    Tragoonrungsea J; Tangbumrungtham N; Nitivanichsakul T; Roongpuvapaht B; Tanjararak K
    Clin Otolaryngol; 2023 Mar; 48(2):182-190. PubMed ID: 36336851
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Topical platelet-rich plasma as a possible treatment for olfactory dysfunction-A randomized controlled trial.
    Duffy A; Naimi B; Garvey E; Hunter S; Kumar A; Kahn C; Farquhar D; D'Souza G; Rawson N; Dalton P; Toskala E; Rabinowitz M; Rosen M; Nyquist G; Rosen D
    Int Forum Allergy Rhinol; 2024 Sep; 14(9):1455-1464. PubMed ID: 38722276
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.